I had dose dense chemotherapy and gave myself 8 neupogen shots in between treatments. It shortened the wait time between treatments, helping me to get past it sooner. I got used to the shots, and my white counts were never too low that I couldn't have treatment. The Taxol recovery was nothing like the AC. AC was 2 really awful fluelike days following the day after treatment. Then I'd get up and rejoin the human race. Taxol was a little fatigue, body aches and tingling in my feet sometimes. I was told Taxotere could only be administered 3 weeks apart. Instead of ordering the 8 shots of neupogen after the last treatment I gave myself one neulasta shot, because they last longer. A month later I had a mastectomy and tram reconstruction. If you want further info on my situation, let me know, as there were some other issues with the chemo.
Dear EllenFitz: The rationale for doing AC+T sequentially is toxicity, especially in the dose-dense setting. Early trials have suggested that there may be advantange to doing dose-dense therapy over the every three week schedule. There is no advantage to neulasta over neupogen. However, due to the duration of neulasta, neupogen may be preferred in the dose-dense setting. The only other potential difference is cost. Neupogen may be a little less expensive.